B6.Cg-Prkntm1Ccs/Ieg

Status

Available to order

EMMA IDEM:14605
International strain nameB6.Cg-Prkntm1Ccs/Ieg
Alternative nameB6.Cg-Park2tm1Hlu
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolPrkntm1Ccs,
Gene/Transgene symbolPrkn

Information from provider

ProviderXinran Zhu
Provider affiliationLehrstuhl für Tierphysiologie, Ruhr-Universität Bochum
Genetic informationA targeting construct in which the Parkin exons 3, was replaced with a neomycin (Neo) selectable cassette flanked with two loxP elements. The neomycin (Neo) selectable cassette was subsequently deleted by crossing with a cre deleter strain. RT-PCR shows that exon 2 splices to exon 4, skipping exon 3 entirely, resulting in a frame shift and a premature stop codon in exon 5.
Phenotypic informationHomozygous:
Parkin-knockout mice (PaKO) were viable, fertile, and showed no gross anatomical or neuronal abnormalities. Dopaminergic neuron (DA) numbers in the substantia nigra and fiber densities and dopamine levels in the striatum were normal. PaKO did not enhance vulnerability of dopaminergic neurons to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity. However, they displayed impaired exploration and habituation to a new environment and exhibited thigmotaxis behaviour in the open field and Morris water maze. Abnormal anxiety-related behaviour of PaKO was also observed in the light/dark exploration test paradigm. Dopamine metabolism was enhanced in the striatum of mutant mice, as revealed by increased homovanillic acid (HVA) content and a reduced ratio of dihydroxyphenylacetic acid (DOPAC) ⁄HVA. The alterations found in the dopaminergic system could be responsible for the behavioural impairments of PaKO mice. Accumulation of damaged mitochondrion were observed in DA neurons and in glia cells within the region as well, suggesting abnormal mitophagy in Da system of PaKO mice.

Heterozygous:
It has not been investigated so far
Breeding historyBackcrossed to C57BL/6 for 20 generations
References
  • Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage.;Stichel Christine C, Zhu Xin-Ran, Bader Verian, Linnartz Bettina, Schmidt Saskia, Lübbert Hermann, ;2007;Human molecular genetics;16;2377-93; 17412759
  • Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria.;Schmidt Saskia, Linnartz Bettina, Mendritzki Sonja, Sczepan Teresa, Lübbert Matthias, Stichel Christine C, Lübbert Hermann, ;2011;Human molecular genetics;20;1197-211; 21212098
  • Non-motor behavioural impairments in parkin-deficient mice.;Zhu Xin-Ran, Maskri Lyutha, Herold Christina, Bader Verian, Stichel Christine C, Güntürkün Onur, Lübbert Hermann, ;2007;The European journal of neuroscience;26;1902-11; 17883413
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreHelmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany
Animals used for archivinghomozygous C57BL/6

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

Literature references

  • Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage.;Stichel Christine C, Zhu Xin-Ran, Bader Verian, Linnartz Bettina, Schmidt Saskia, Lübbert Hermann, ;2007;Human molecular genetics;16;2377-93; 17412759
  • Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria.;Schmidt Saskia, Linnartz Bettina, Mendritzki Sonja, Sczepan Teresa, Lübbert Matthias, Stichel Christine C, Lübbert Hermann, ;2011;Human molecular genetics;20;1197-211; 21212098
  • Non-motor behavioural impairments in parkin-deficient mice.;Zhu Xin-Ran, Maskri Lyutha, Herold Christina, Bader Verian, Stichel Christine C, Güntürkün Onur, Lübbert Hermann, ;2007;The European journal of neuroscience;26;1902-11; 17883413

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).